AAAAAA

   
Results: 1-11 |
Results: 11
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology
Authors: Bast, RC Ravdin, P Hayes, DF Bates, S Fritsche, H Jessup, JM Kemeny, N Locker, GY Mennel, RG Somerfield, MR
Citation: Rc. Bast et al., 2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology, J CL ONCOL, 19(6), 2001, pp. 1865-1878
2000 update of recommendations for the use of tumor markets in breast and colorectal cancer: Clinical practice guidelines for the American Society ofClinical Oncology (vol 19, pg 1865, 2001)
Authors: Bast, RC Ravdin, P Hayes, DF Bates, S Fritsche, H Jessup, JM Kemeny, N Locker, GY Mennel, RG Somerfield, MR
Citation: Rc. Bast et al., 2000 update of recommendations for the use of tumor markets in breast and colorectal cancer: Clinical practice guidelines for the American Society ofClinical Oncology (vol 19, pg 1865, 2001), J CL ONCOL, 19(21), 2001, pp. 4185-4188
Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer
Authors: Kemeny, N Gonen, M Sullivan, D Schwartz, L Benedetti, F Saltz, L Stockman, J Fong, Y Jarnagin, W Bertino, J Tong, W Paty, P
Citation: N. Kemeny et al., Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer, J CL ONCOL, 19(10), 2001, pp. 2687-2695
Hepatic artery infusion chemotherapy for metastatic colorectal carcinoma
Authors: Koea, JB Kemeny, N
Citation: Jb. Koea et N. Kemeny, Hepatic artery infusion chemotherapy for metastatic colorectal carcinoma, SEM SURG ON, 19(2), 2000, pp. 125-134
Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer- Reply
Authors: Kemeny, N Huang, Y Fong, Y
Citation: N. Kemeny et al., Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer- Reply, N ENG J MED, 342(20), 2000, pp. 1526-1527
Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylatesynthase
Authors: Banerjee, D Gorlick, R Liefshitz, A Danenberg, K Danenberg, PC Danenberg, PV Klimstra, D Jhanwar, S Cordon-Cardo, C Fong, Y Kemeny, N Bertino, JR
Citation: D. Banerjee et al., Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylatesynthase, CANCER RES, 60(9), 2000, pp. 2365-2367
Intra-abdominal fibrosis after systemic and intraperitoneal therapy containing fluoropyrimidines
Authors: Fata, F Ron, IG Maluf, F Klimstra, D Kemeny, N
Citation: F. Fata et al., Intra-abdominal fibrosis after systemic and intraperitoneal therapy containing fluoropyrimidines, CANCER, 88(11), 2000, pp. 2447-2451
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.
Authors: Kemeny, N Huang, Y Cohen, AM Shi, WJ Conti, JA Brennan, MF Bertino, JR Turnbull, ADM Sullivan, D Stockman, J Blumgart, LH Fong, YM
Citation: N. Kemeny et al., Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer., N ENG J MED, 341(27), 1999, pp. 2039-2048
5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma
Authors: Fata, F Ron, IG Kemeny, N O'Reilly, E Klimstra, D Kelsen, DP
Citation: F. Fata et al., 5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma, CANCER, 86(7), 1999, pp. 1129-1134
Utility of F-18-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases
Authors: Fong, YM Saldinger, PF Akhurst, T Macapinlac, H Yeung, H Finn, RD Cohen, A Kemeny, N Blumgart, LH Larson, SM
Citation: Ym. Fong et al., Utility of F-18-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases, AM J SURG, 178(4), 1999, pp. 282-287
Phase I clinical and pharmacologic study of weekly cisplatin combined withweekly irinotecan in patients with advanced solid tumors
Authors: Saltz, LB Spriggs, D Schaaf, LJ Schwartz, GK Ilson, D Kemeny, N Kanowitz, J Steger, C Eng, M Albanese, P Semple, D Hanover, CK Elfring, GL Miller, LL Kelsen, D
Citation: Lb. Saltz et al., Phase I clinical and pharmacologic study of weekly cisplatin combined withweekly irinotecan in patients with advanced solid tumors, J CL ONCOL, 16(12), 1998, pp. 3858-3865
Risultati: 1-11 |